DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Enobosarm
Enobosarm
Androgen Receptor: a Complex Therapeutic Target for Breast Cancer
Cancer Palliative Care and Anabolic Therapies
UFC PROHIBITED LIST Effective June 1, 2021 the UFC PROHIBITED LIST
Anti-Cytokines in the Treatment of Cancer Cachexia
Pushing Estrogen Receptor Around in Breast Cancer
The Selective Androgen Receptor Modulator Gtx-024
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
The Long and Winding Road for Selective Androgen Receptor Modulators
Pharmacological Treatments
April 2020 Sanctions List Full
Enobosarm As a Treatment for Stress Urinary
Novel Trifluoromethylated Enobosarm Analogues with Potent Anti- Androgenic Activity in Vitro and Tissue Selectivity in Vivo
Anti-Doping Manual Revised Dec. 2018
2019 Prohibited List
Design and Synthesis of Novel Bicalutamide and Enzalutamide Derivatives As Antiproliferative Agents for the Treatment of Prostate Cancer
FDHT-PET to Predict Bicalutamide Efficacy in Patients with Androgen
Original Articles Reviews
Synthesis and Biological Evaluation of Bicalutamide Analogues for the Potential Treatment of Prostate Cancer
Top View
Prohibited List 2021
Novel Trifluoromethylated Enobosarm Analogues with Potent Anti- Androgenic Activity in Vitro and Tissue Selectivity in Vivo
Anti-Doping Convention
Targeting the Androgen Receptor in Triple-Negative Breast Cancer: Current Perspectives
A New Generation of Selective Androgen Receptor Degraders: Our Initial Design
Drug Repurposing for Triple-Negative Breast Cancer
Pushing Estrogen Receptor Around in Breast Cancer
WADA Technical Letter – TL12 ENOBOSARM (OSTARINE) 1.0
Prohibited List January 2019
Atletas Suspensos Em Definitivo 24-03.Xlsx
Sarms, Peptides, and Other Emerging Drugs. “The Only Thing That Is Constant Is Change.”
Signaling Pathways and Steroid Receptors Modulating Estrogen Receptor Α Function in Breast Cancer
Banned Substances
Examples of Prohibited and Permitted Substances And
Androgen and Estrogen Actions on Male Physical Activity: a Story Beyond Muscle
Sarms): a New Class of Muscle Building Agents
Androgens and Androgen Receptor Actions on Bone Health and Disease: from Androgen Deficiency to Androgen Therapy
Download Author Version (PDF)
Swansea University Open Access Repository
Androgen Receptor Antagonism Drives Cytochrome P450 17A1 Inhibitor Efficacy in Prostate Cancer
Banned Substances in Sports Supplements
Enobosarm (Ostarine) for Cachexia in Patients with Advanced Non-Small Cell Lung Cancer – First Line
Discovery of Novel Androgen Receptor Inhibitors As Prospective Therapeutics for Advanced Prostate Cancer By
1 a New Series of Bicalutamide, Enzalutamide and Enobosarm
Prevention of Body Weight Loss and Sarcopenia by a Novel Selective Androgen Receptor Modulator in Cancer Cachexia Models
An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer
Effect of Ostarine (Enobosarm/Gtx024), a Selective Androgen Receptor Modulator, on Adipocyte Metabolism in Wistar Rats
Metabolism of Doping Agents Using in Vitro and in Vivo Models
2020 Prohibited List
Novel Trifluoromethylated Enobosarm Analogues with Potent Antiandrogenic Activity in Vitro and Tissue Selectivity in Vivo
Abiraterone Shows Alternate Activity in Models of Endocrine Resistant and Sensitive Disease
The Long and Winding Road for Selective Androgen Receptor
Experimental Drug Improves Muscle Strength Among Male Cancer Patients 25 June 2012
Prescrire's Contribution to the WHO Consultation on List 107 of Proposed Inns
Oestrogens, Androgens and Endometrial Disorders
Medicinal Use of Testosterone and Related Steroids Revisited
LPGA Prohibited Substances List
Pharmacological Management of Cachexia in Adult Cancer Patients: a Systematic Review of Clinical Trials Shailesh M
Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications
Cachexia Syndrome: Pharmacological and Non-Pharmacological
A Review of Estrogen Receptor/Androgen Receptor